Stock RSPI RESPIRERX PHARMACEUTICALS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Relative Strength Chart RespireRx Pharmaceuticals Inc.

Equities

RSPI

US7612273059

Market Closed - OTC Markets
Other stock markets
 15:59:47 2024-06-07 EDT 		5-day change 1st Jan Change
0.002 USD -4.76% Intraday chart for RespireRx Pharmaceuticals Inc. -39.39% +122.22%
04-10 RespireRx Pharmaceuticals Inc. announced that it has received $0.1 million in funding CI
03-20 RespireRx Pharmaceuticals Inc. Reports Publication of Preclinical Research Results Demonstrating the Ability of CX1739, its Lead Clinical AMPAkine, to Improve Bladder Function After Spinal Cord Injury CI

End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
RESPIRERX PHARMACEUTICALS INC.
Bio Therapeutic Drugs
-4.76%-39.39%+122.22%-33.33%-99.97% 1.61M - - -
  1. Stock Market
  2. Equities
  3. RSPI Stock
  4. Charts RespireRx Pharmaceuticals Inc.
  5. Relative Strength Chart